TEVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teva Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 39.13 USD -2.71% Market Closed

Market Cap: $44.3B

	Teva Pharmaceutical Industries Ltd NYSE:TEVA	IL
	Amcor PLC F:4850	CH
T	Teradyne Inc F:TEY	US
G	Gecina SA SWB:GI6A	FR
	BTC Health Ltd ASX:BTC	AU
N	NOS SGPS SA SWB:PMV	PT
	nCino OpCo, Inc. NASDAQ:NCNO	US
N	Novita SA WSE:NVT	PL

Profitability Summary

Teva Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

49% > 53%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

22%

Declining Operating Margin

21% > 19%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-15% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

8% > 8%

Low ROE

10%

Negative 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

9% > 10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.